Tuberkulózis: vizsgálatok itt: Peru
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in PeruRe-evaluating the Duration in Children of TB Treatment
- Where
- Lima
- Életkor
- 3 hónap to 9 év
- People
- 230
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT07656012 - 3. fázisTaking peopleA Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
- Where
- La Molina, Lima, Villa El Salvador
- Életkor
- 14 év and over
- People
- 532 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT07209761 - 2/3. fázisTaking peopleBedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
- Where
- Lima
- People
- 2530 worldwide
- Run by
- Johns Hopkins University
See details and how to joinNCT06568484 - No phaseTaking peopleBioneer Q-RFIA Clinical Evaluation
- Where
- Lima
- Életkor
- 18 év and over
- People
- 2350 worldwide
- Run by
- Foundation for Innovative New Diagnostics, Switzerland
See details and how to joinNCT05117788 - 1. fázisNot yet taking people in PeruA Clinical Study of the HCMV-TB Vaccine Candidate VIR-1778 in Healthy Adults
- Where
- Iquitos, Lima
- Életkor
- 18 év to 55 év
- People
- 116
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07818824 - 2/3. fázisTaking peopleProgram for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
- Where
- Lima
- Életkor
- 14 év and over
- People
- 400 worldwide
- Run by
- University of California, San Francisco
See details and how to joinNCT06441006 - 2. fázisNot yet taking people in PeruA Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
- Where
- Callao, Lima
- Életkor
- 13 év and over
- People
- 900 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07595042 - 2. fázisTaking peopleTrial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
- Where
- Lima
- Életkor
- 15 év and over
- People
- 330 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05383742